129 related articles for article (PubMed ID: 38069862)
1. CD30 plays a role in T-dependent immune response and T cell proliferation.
Cui D; Zhang Y; Chen L; Du H; Zheng B; Huang M; Li X; Wei J; Chen Q
FASEB J; 2024 Jan; 38(1):e23365. PubMed ID: 38069862
[TBL] [Abstract][Full Text] [Related]
2. TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism.
Harlin H; Podack E; Boothby M; Alegre ML
J Immunol; 2002 Sep; 169(5):2451-9. PubMed ID: 12193714
[TBL] [Abstract][Full Text] [Related]
3. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
[TBL] [Abstract][Full Text] [Related]
4. CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses.
Chan KW; Hopke CD; Krams SM; Martinez OM
J Immunol; 2002 Aug; 169(4):1784-91. PubMed ID: 12165500
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors.
Lee SY; Park CG; Choi Y
J Exp Med; 1996 Feb; 183(2):669-74. PubMed ID: 8627180
[TBL] [Abstract][Full Text] [Related]
6. The TNF receptor family member CD30 is not essential for negative selection.
DeYoung AL; Duramad O; Winoto A
J Immunol; 2000 Dec; 165(11):6170-3. PubMed ID: 11086050
[TBL] [Abstract][Full Text] [Related]
7. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J ; Herrmann F
Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
[TBL] [Abstract][Full Text] [Related]
8. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
[TBL] [Abstract][Full Text] [Related]
9. CD30L/CD30 is critical for maintenance of IL-17A-producing γδ T cells bearing Vγ6 in mucosa-associated tissues in mice.
Sun X; Shibata K; Yamada H; Guo Y; Muta H; Podack ER; Yoshikai Y
Mucosal Immunol; 2013 Nov; 6(6):1191-201. PubMed ID: 23549449
[TBL] [Abstract][Full Text] [Related]
10. CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury.
Sato Y; Oguchi A; Fukushima Y; Masuda K; Toriu N; Taniguchi K; Yoshikawa T; Cui X; Kondo M; Hosoi T; Komidori S; Shimizu Y; Fujita H; Jiang L; Kong Y; Yamanashi T; Seita J; Yamamoto T; Toyokuni S; Hamazaki Y; Hattori M; Yoshikai Y; Boor P; Floege J; Kawamoto H; Murakawa Y; Minato N; Yanagita M
J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 34813503
[TBL] [Abstract][Full Text] [Related]
11. CD30-governor of memory T cells?
Podack ER; Strbo N; Sotosec V; Muta H
Ann N Y Acad Sci; 2002 Dec; 975():101-13. PubMed ID: 12538158
[TBL] [Abstract][Full Text] [Related]
12. Role of CD30 in B/T segregation in the spleen.
Bekiaris V; Withers D; Glanville SH; McConnell FM; Parnell SM; Kim MY; Gaspal FM; Jenkinson E; Sweet C; Anderson G; Lane PJ
J Immunol; 2007 Dec; 179(11):7535-43. PubMed ID: 18025198
[TBL] [Abstract][Full Text] [Related]
13. cis interaction of CD153 with TCR/CD3 is crucial for the pathogenic activation of senescence-associated T cells.
Fukushima Y; Sakamoto K; Matsuda M; Yoshikai Y; Yagita H; Kitamura D; Chihara M; Minato N; Hattori M
Cell Rep; 2022 Sep; 40(12):111373. PubMed ID: 36130493
[TBL] [Abstract][Full Text] [Related]
14. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice.
Amakawa R; Hakem A; Kundig TM; Matsuyama T; Simard JJ; Timms E; Wakeham A; Mittruecker HW; Griesser H; Takimoto H; Schmits R; Shahinian A; Ohashi P; Penninger JM; Mak TW
Cell; 1996 Feb; 84(4):551-62. PubMed ID: 8598042
[TBL] [Abstract][Full Text] [Related]
15. Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory.
Gaspal FM; Kim MY; McConnell FM; Raykundalia C; Bekiaris V; Lane PJ
J Immunol; 2005 Apr; 174(7):3891-6. PubMed ID: 15778343
[TBL] [Abstract][Full Text] [Related]
16. CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease.
Blazar BR; Levy RB; Mak TW; Panoskaltsis-Mortari A; Muta H; Jones M; Roskos M; Serody JS; Yagita H; Podack ER; Taylor PA
J Immunol; 2004 Sep; 173(5):2933-41. PubMed ID: 15322151
[TBL] [Abstract][Full Text] [Related]
17. Cross-linking of CD30 induces HIV expression in chronically infected T cells.
Biswas P; Smith CA; Goletti D; Hardy EC; Jackson RW; Fauci AS
Immunity; 1995 Jun; 2(6):587-96. PubMed ID: 7540942
[TBL] [Abstract][Full Text] [Related]
18. Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis.
Artinger K; Kirsch AH; Mooslechner AA; Cooper DJ; Aringer I; Schuller M; Schabhüttl C; Klötzer KA; Schweighofer K; Eller P; Yagita H; Illert AL; Rosenkranz AR; Lane PJ; Eller K
Kidney Int; 2021 Aug; 100(2):336-348. PubMed ID: 33785369
[TBL] [Abstract][Full Text] [Related]
19. CD30 prevents T-cell responses to non-lymphoid tissues.
Heath WR; Kurts C; Caminschi I; Carbone FR; Miller JF
Immunol Rev; 1999 Jun; 169():23-9. PubMed ID: 10450505
[TBL] [Abstract][Full Text] [Related]
20. Critical roles of CD30/CD30L interactions in murine autoimmune diabetes.
Chakrabarty S; Nagata M; Yasuda H; Wen L; Nakayama M; Chowdhury SA; Yamada K; Jin Z; Kotani R; Moriyama H; Shimozato O; Yagita H; Yokono K
Clin Exp Immunol; 2003 Sep; 133(3):318-25. PubMed ID: 12930356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
